96819 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
T-CELL IMMUNOTHERAPY
#2VACCINE AGAINST CAMPYLOBACTER JEJUNI
#3Antigenic Epstein Barr Virus Polypeptides
#4VACCINATION WITH MICA/B ALPHA 3 DOMAIN FOR THE TREATMENT OF CANCER
#5POROUS PROTEIN MICROCRYSTALS AS A SCAFFOLD FOR NUCLEIC ACIDS AND PROTEINS
#6NOVEL PEPTIDES AND THEIR USE IN DIAGNOSIS
#7OPTIMIZED NUCLEIC ACID MOLECULES
#8CRISPR/CAS FUSION PROTEINS AND SYSTEMS
#9COMPOSITION FOR INHIBITING GROWTH OF BACTERIUM HAVING MENAQUINONE SYNTHESIS PATHWAY THROUGH FUTALOSINE OR FUTALOSINE DERIVATIVE
#10Peptides and their use in diagnosis
#11QUANTIFICATION OF BIOCONJUGATE GLYCOSYLATION
#12MODIFIED CARRIER PROTEINS FOR O-LINKED GLYCOSYLATION
#13CONSTRUCTION AND USE OF TANDEM EPITOPE POLYPEPTIDE OF OUTER MEMBRANE PROTEIN OF CAMPYLOBACTER JEJUNI, GENE, RECOMBINANT PLASMID AND RECOMBINANT BACTERIA
#14METHOD FOR DIAGNOSING INFECTION WITH HELICOBACTER SUIS
#15Food safety vaccine to control and reduce in poultry
#16CRISPR/Cas fusion proteins and systems
#17OPTIMIZED NUCLEIC ACID MOLECULES
#18Campylobacter immunogenic compositions and uses thereof
#19CRISPR/Cas fusion proteins and systems
#20Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease
#21Protein coated polymeric substrate
#22Peptides and their use in diagnosis
#23Composition for inhibiting growth of bacterium having menaquinone synthesis pathway through futalosine or futalosine derivative
#24Food safety vaccine to control and reduce campylobacter in poultry
#25T-CELL IMMUNOTHERAPY
#26Campylobacter immunogenic compositions and uses thereof
#27Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#28vaccines
#29Recombinant lactic acid bacteria and the use thereof in oral universal influenza vaccine
#30OPTIMIZED NUCLEIC ACID MOLECULES
#31CAMPYLOBACTER JEJUNI PEPTIDE FOR VACCINE DEVELOPMENT
#32Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#33Method of Diagnosing Bacterial Infections Using Bacterial Glycoproteins
#34Engineered programmable molecular scaffolds from porous protein crystals
#35Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteins
#36Compositions produced using enteric pathogens and methods of use
#37Compositions produced using enteric pathogens and methods of use
#38Compositions produced using enteric pathogens and methods of use
#39Compositions produced using enteric pathogens and methods of use
#40Tolerogenic compositions comprising and uses thereof
#41Use of heliocbacter pylori extract for treating or preventing inflammatory bowel diseases and coeliac disease
#42Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette thereof
#43Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#44Protein coated polymeric substrate
#45Campylobacter immunogenic compositions and uses thereof
#46Peptides derived from Campylobacter jejuni and their use in vaccination
#47Compositions produced using enteric pathogens and methods of use
#48Antibiotic peptide derived from ribosomal protein L1 and uses thereof
#49CAMPYLOBACTER BACTERIA AND DETECTION
#50Vaccine and methods to reduce campylobacter infection
#51Deletion mutants of flagellin and methods of use
#52SELF-ASSEMBLED NANOPARTICLE VACCINES
#53Deletion mutants of flagellin and methods of use
#54immunogenic compositions and uses thereof
#55Recombinant N-glycosylated proteins from procaryotic cells
#56Influenza hemagglutinin protein-based vaccines
#57Peptides derived from and their use in vaccination
#58Multi-Target recombination gene and the application of its protein to prevent and cure
#59Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#60Method for one-step purification of recombinant neutrophil-activating protein
#61Vaccine and methods to reduce campylobacter infection
#62Campylobacter polypeptides and methods of use
#63Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target
#64Antigen compositions and methods of inhibiting bacterial infection and uses of the antigen compositions
#65system and uses thereof
#66Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#67Compositions Produced Using Enteric Pathogens and Methods of Use
#68vaccines
#69Oral recombinant vaccine and preparing method thereof
#70Deletion mutants of flagellin and methods of use
#71Biomolecule-immobilized carrier and method for immobilizing biomolecule on carrier
#72Replikin peptides in rapid replication of glioma cells and in influenza epidemics
#73System and method for identifying complex patterns of amino acids
#74REPLIKINS AND METHODS OF IDENTIFYING REPLIKIN-CONTAINING SEQUENCES
#75REPLIKIN PEPTIDES AND ANTIBODIES THEREFOR
#76Helicobacter pylori sialic acid binding adhesin, SabA and sabA - gene
#77Compositions produced using enteric pathogens and methods of use
#78Cytolethal distending toxins and detection of bacteria using the same as a target
#79Recombinant N-glycosylated proteins from procaryotic cells
#80Cytolethal distending toxins and detection of bacteria using the same as a target
#81REPLIKIN PEPTIDES IN RAPID REPLICATION OF GLIOMA CELLS AND IN INFLUENZA EPIDEMICS
#82CYTOTOXIC PROTEIN AND UTLIZATION THEREOF
#83Replikin peptides in rapid replication of glioma cells and in influenza epidemics
#84Biomarkers and detection methods for gastric diseases
#85Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#86REPLIKIN PEPTIDES AND ANTIBODIES THEREFORE
#87Replikins and methods of identifying replikin-containing sequences
#88CYTOTONIC PROTEIN AND UTLIZATION THEREOF
#89HELICOBACTER PYLORI ADHESIN BINDING GROUP ANTIGEN
#90Biomarkers and detection methods for gastric diseases
#91Vaccine And Nucleic Acids Capable Of Protecting Poultry Against Colonisation By Campylobacter
#92Helicobacter pylori proteins useful for vaccines and diagnostics
#93Cytolethal distending toxins and detection of bacteria using the same as a target
#94Surface-located campylobacter jejuni polypeptides
#95system and uses thereof
#96Td antigens
#97Process for production of bacterioferritin
#98Helicobacter proteins and vaccines
#99Replikin peptides in rapid replication of glioma cells and in influenza epidemics
#100Methods for treating, preventing and diagnosing Helicobacter infection
#101Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
#102Cytotoxic protein and utilization thereof
#103Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses
#104Essential novel bacterial polypeptides
#105System and method for identifying complex patterns of amino acids
#106Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
#107CAI antigen
#108vaccine
#109Novel therapeutic compositions for treating infection by Lawsonia spp.
#110Novel purified polypeptides from bacteria
#111Novel purified polypeptides from Streptococcus pneumoniae
#112Compositions produced using enteric pathogens and methods of use
#113Novel purified polypeptides from bacteria
#114Expression of lipoproteins
#115Immunogenic peptides and uses thereof
#116H. pylori FlbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori FlbA polypeptides, and compositions for detection of an infection comprising H. pylori FlbA polypeptides
#117LAWSONIA INTRACELLULARIS PROTEINS, AND RELATED METHODS AND MATERIALS
#118polypeptides and methods of use
#119Lawsonia intracellularis vaccine
#120Proteins, in particular membrane proteins, of Helicobacter pylori, their preparation and use
#121Compositions, test kits and methods for detecting helicobacter pylori
#122antigens in blood